Nicola Davies, PhD

Following the reversal of Roe vs Wade, Audrey Nath, MD, PhD, discusses its implications on neurologists and the standard neurologic care they provide for their patients.

A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of degeneration.

Drs Joshua Rotenberg and Deepa Menon both explain how neurologists facilitate an ASD diagnosis by addressing the common neurological comorbidities in ASD.

Lavanya Visvabharathy, PhD, Anna Cervantes-Arslanian, MD, and Jonathan Rogers, PhD, provide a closer look into the phenomenon known as “long-haul COVID” and its potential neurologic effects.

Two neurologists explain the importance of virtual residency recruitment to promote diversity, equity, and inclusion in neurology, and the future of hybrid recruitment and its challenges.

Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.

Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.

Dr Nicola Davies discusses the potential of deep brain stimulation for the treatment of chronic pain.

Research has revealed that the SARS-CoV-2 viral infection may have neurological manifestations, with critical implications for clinical practice.

As rates of physician burnout continue to climb, a diverse group of researchers weigh in on enhancing resilience and particularly emphasize enlightening educators about how resilience develops during residency.